ENDRA Life Sciences Inc. (NDRA) Operating cash flow 2016–2025
ENDRA Life Sciences Inc. (NDRA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$5.2MFY2025 · since FY2016: -$1.3M → -$5.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$5.2M | +30.0% |
| FY2024 | -$7.4M | +22.5% |
| FY2023 | -$9.5M | +25.2% |
| FY2022 | -$12.8M | -14.8% |
| FY2021 | -$11.1M | -3.5% |
| FY2020 | -$10.7M | -25.1% |
| FY2019 | -$8.6M | -11.5% |
| FY2018 | -$7.7M | -133.3% |
| FY2017 | -$3.3M | -150.9% |
| FY2016 | -$1.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice